Table 2 Time at risk and observed outcomes by state populations.

From: The natural history of symptomatic COVID-19 during the first wave in Catalonia

   From general population From diagnosed with COVID-19 From hospitalised with COVID-19
Follow-up in days To diagnosis with COVID-19 To hospitalised with COVID-19 To death Follow-up in days To hospitalised with COVID-19 To death Follow-up in days To death
Median (min, IQR, max) Events (cumulative incidence at 67 days) Events (cumulative incidence at 67 days) Events (cumulative incidence at 67 days Median (min, IQR, max) Events (cumulative incidence at 45 days) Events (cumulative incidence at 45 days) Median (min, IQR, max) Events (cumulative incidence at 45 days)
All   67 (1, 67–67, 67) 102,002 (1.83%) 8041 (0.14%) 11,327 (0.20%) 35 (0, 19–44, 66) 8860 (9.06%) 2581 (3.01%) 36 (0, 25–43, 65) 2692 (19.16%)
Age Under 18 67 (1, 67–67, 67) 4536 (0.47%) 34 (0.0035%) 9 (0.00093%) 29 (0, 16–40, 65) 40 (0.96%) <5 28 (0, 19–41.75, 55) <5
Age 18–39 67 (1, 67–67, 67) 30,530 (2.13%) 426 (0.03%) 80 (0.0056%) 37 (0, 22 to 44, 66) 850 (2.91%) 5 (0.031%) 36 (0, 26.75–43, 65) 11 (1.15%)
Age 40–59 67 (1, 67–67, 67) 44,493 (2.49%) 1776 (0.10%) 657 (0.037%) 37 (0, 22–44, 66) 3441 (8.05%) 63 (0.18%) 37 (0, 29–43, 65) 142 (3.54%)
Age 60–69 67 (1, 67–67, 67) 10,305 (1.67%) 1558 (0.25%) 1026 (0.17%) 34 (0, 14–44, 65) 1673 (16.82%) 131 (1.51%) 38 (0, 30–44, 64) 292 (10.80%)
Age 70–79 67 (1, 67–67, 67) 6120 (1.31%) 2162 (0.46%) 1967 (0.42%) 24 (0, 7–40, 65) 1602 (27.21%) 406 (8.07%) 37 (0, 26–43, 65) 822 (24.97%)
Age 80 or older 67 (1, 67–67, 67) 6018 (1.93%) 2085 (0.67%) 7588 (2.43%) 16 (0, 7–31, 62) 1254 (21.72%) 1976 (40.84%) 27 (0, 14–39.5, 65) 1424 (51.31%)
Sex Male 67 (1, 67–67, 67) 42,996 (1.56%) 4602 (0.17%) 5655 (0.21%) 35 (0, 16–44, 66) 4871 (11.80%) 1114 (3.13%) 37 (0, 26–43, 65) 1617 (20.46%)
Sex Female 67 (1, 67–67, 67) 59,006 (2.09%) 3439 (0.12%) 5672 (0.20%) 35 (0, 20–44, 66) 3989 (7.06%) 1467 (2.93%) 36 (0, 24 to 43, 65) 1075 (17.43%)
Region Barcelona 67 (1, 67–67, 67) 82,702 (1.98%) 7201 (0.17%) 8694 (0.21%) 36 (0, 19–44, 66) 7604 (9.56%) 2164 (3.10%) 37 (0, 26–43, 65) 2393 (19.20%)
Region Girona 67 (1, 67–67, 67) 9929 (1.78%) 432 (0.078%) 942 (0.17%) 35 (0, 18–44, 66) 657 (6.99%) 217 (2.55%) 32 (0, 17–41, 65) 158 (17.48%)
Region Lleida 67 (2, 67–67, 67) 5621 (1.52%) 211 (0.057%) 728 (0.20%) 33 (0, 16–43, 65) 391 (7.35%) 108 (2.45%) 35 (0, 22–41, 64) 94 (22.27%)
Region Tarragona 67 (1, 67–67, 67) 3748 (0.77%) 196 (0.04%) 958 (0.20%) 30 (0, 16–42, 66) 207 (5.82%) 92 (3.00%) 33 (0, 22–42, 64) 45 (15.92%)
Charlson 0 67 (1, 67–67, 67) 80,214 (1.76%) 3627 (0.08%) 1613 (0.035%) 36 (0, 21–44, 66) 5385 (7.01%) 365 (0.55%) 37 (0, 29–43, 65) 583 (8.20%)
Charlson 1 67 (1, 67–67, 67) 8996 (2.25%) 1036 (0.26%) 1607 (0.40%) 33 (0, 15–43, 65) 1031 (11.93%) 519 (6.82%) 36 (0, 23–43, 65) 427 (24.22%)
Charlson 2 67 (2, 67–67, 67) 6846 (1.91%) 1409 (0.39%) 2304 (0.64%) 30 (0, 11–43, 65) 1164 (17.70%) 460 (8.16%) 36 (0, 23–43, 65) 559 (25.21%)
Charlson 3+ 67 (1, 67–67, 67) 5946 (2.20%) 1969 (0.73%) 5803 (2.15%) 19 (0, 7–36, 64) 1280 (22.53%) 1237 (25.66%) 31 (0, 17–41, 65) 1123 (41.51%)
Autoimmune condition   67 (2, 67–67, 67) 6251 (2.29%) 806 (0.29%) 1285 (0.47%) 34 (0, 16–44, 64) 727 (12.10%) 275 (5.09%) 35 (0, 22–42, 65) 326 (25.11%)
Chronic kidney disease   67 (1, 67–67, 67) 3934 (1.95%) 1408 (0.70%) 3710 (1.84%) 19 (0, 7–35, 62) 892 (23.67%) 887 (27.36%) 31 (0, 17–41, 64) 819 (42.57%)
COPD   67 (2, 67–67, 67) 2359 (1.97%) 740 (0.62%) 1457 (1.22%) 22 (0, 8–40, 65) 463 (20.64%) 261 (13.68%) 33 (0, 19–42, 65) 363 (36.26%)
Dementia   67 (1, 67–67, 67) 1933 (4.54%) 429 (1.01%) 2701 (6.35%) 15 (0, 8–25, 59) 294 (15.92%) 990 (64.07%) 21 (0.5, 12 to 34, 65) 376 (64.59%)
Heart disease   67 (1, 67–67, 67) 10,732 (2.01%) 2611 (0.49%) 5686 (1.07%) 28 (0, 10–41, 65) 1903 (18.46%) 1175 (13.20%) 34 (0, 19–42, 65) 1324 (34.22%)
Hyperlipidemia   67 (1, 67–67, 67) 10,820 (2.10%) 1498 (0.29%) 1580 (0.31%) 34 (0, 15–43, 65) 1507 (14.48%) 381 (4.18%) 37 (0, 27–43, 65) 508 (20.40%)
Malignant neoplasm   67 (1, 67–67, 67) 5595 (1.92%) 1327 (0.46%) 3751 (1.29%) 29 (0, 10–42, 65) 991 (18.37%) 588 (12.70%) 34 (0, 20–43, 65) 670 (34.19%)
Obesity   67 (1, 67–67, 67) 20,761 (2.24%) 3216 (0.35%) 3184 (0.34%) 33 (0, 14–43, 66) 3103 (15.52%) 695 (3.94%) 37 (0, 25–43, 65) 1088 (20.03%)
Type 2 diabetes   67 (2, 67–67, 67) 6000 (1.89%) 1644 (0.52%) 2612 (0.82%) 25 (0, 8–41, 64) 1284 (22.30%) 590 (11.77%) 35 (0, 22–42, 65) 710 (28.50%)
  1. Counts of less than 5 have been obscured to protect patient privacy.
  2. COPD chronic obstructive pulmonary disease, IQR interquartile range.